Meningococcal B Vaccine Fails to Protect Against Gonorrhea
A new randomized controlled trial (RCT) published in the New England Journal of Medicine (NEJM) has found that the Meningitis B vaccine does not prevent gonorrhea infections despite a year-long mass vaccination campaign targeting at-risk men in the United Kingdom. After gonorrhea cases exceeded the highest levels ever recorded, the U.K.’s National Health Service (NHS) […]
CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]